Clincosm LogoSign in Get a demo

Colorectal Carcinoma

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Carcinoma Trial in Los Angeles (Best Practice, Consultation, Educational Intervention)

Recruiting
  • Colorectal Carcinoma
  • Best Practice
  • +8 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Hispanic Patient Engagement in Colorectal Cancer Genomics,

Recruiting
  • Colorectal Carcinoma
  • Archive Sample Retrieval
  • +4 more
  • Los Angeles, California
  • +1 more
Sep 25, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Non-small-cell Lung Cancer
  • +5 more
  • PF-07209960
  • Duarte, California
  • +11 more
Oct 10, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Nivolumab
  • +3 more
  • Birmingham, Alabama
  • +101 more
Jun 13, 2022

Nutritional Preferences and Product Accessibility in Oral

Withdrawn
  • Breast Carcinoma
  • +6 more
  • Interview
  • Survey Administration
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 10, 2020

Colorectal Carcinoma, Health Status Unknown, Healthy Subject Trial in United States (Educational Intervention, Informational

Completed
  • Colorectal Carcinoma
  • +2 more
  • Educational Intervention
  • +3 more
  • Los Angeles, California
  • +3 more
Jul 27, 2020

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumor Trial in United States (enzastaurin, irinotecan, cetuximab)

Completed
Has Results
  • Colorectal Cancer
  • +2 more
  • Casa Grande, Arizona
  • +19 more
Jul 20, 2020

Malignant Melanoma, Colorectal Carcinoma Trial in Australia, United States (PLX4032)

Completed
Has Results
  • Malignant Melanoma
  • Colorectal Carcinoma
  • Los Angeles, California
  • +6 more
Aug 18, 2017

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in United States (RAD001, Cetuximab, Irinotecan)

Completed
  • Colorectal Cancer
  • +3 more
  • RAD001, Cetuximab, Irinotecan
  • Fayetteville, Arkansas
  • +15 more
Nov 1, 2012

Colorectal Carcinoma Trial in United States (VELCADE TM (bortezomib) for Injection, or PS-341)

Completed
  • Colorectal Carcinoma
  • VELCADE TM (bortezomib) for Injection, or PS-341
  • Birmingham, Alabama
  • +21 more
Feb 7, 2008